Strides Pharma Science inks pact with MPP to market COVID-19 drug - Moneycontrol

The Pfizer product has been authorised as a COVID-19 oral therapy for emergency use in the US and other countries for high-risk adults and pediatric patients.

Strides Pharma Science on Monday said it has inked a sub-license agreement with Medicines Patent Pool to commercialise a generic version of Pfizer's COVID-19 oral treatment drug in 95 low and middle-… [+1625 chars]

full article...